Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1997
10/28/1997US5681961 Arylsulphonamides, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997US5681858 Cycloalkyl hydroxyureas
10/28/1997US5681577 Multiple action cold/sinus preparations
10/28/1997US5681571 Immunological tolerance-inducing agent
10/28/1997US5681556 Method and compositions for suppressing allograft rejection in mammals
10/25/1997CA2203466A1 Novel specific immunophilin ligands as antiasthmatics and immunosuppressants
10/23/1997WO1997039355A1 Pharmaceutical grade botanical drugs
10/23/1997WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997WO1997039127A1 Hybrid interferon compositions and methods of use
10/23/1997WO1997039126A1 Novel rantes homolog from prostate
10/23/1997WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997WO1997039022A1 Novel compounds
10/23/1997WO1997039018A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/23/1997WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
10/23/1997WO1997039015A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
10/23/1997WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
10/23/1997WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
10/23/1997WO1997038992A1 Piperidinylpyramidine derivatives
10/23/1997WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997WO1997038966A2 Cytoprotective compounds
10/23/1997WO1997038731A1 Immunoliposomes that optimize internalization into target cells
10/23/1997WO1997038722A1 Novel compounds
10/23/1997WO1997038721A1 Novel compounds
10/23/1997WO1997038720A1 Novel compounds
10/23/1997WO1997038719A1 Novel compounds
10/23/1997WO1997038718A1 Novel compounds
10/23/1997WO1997038717A1 Novel compounds
10/23/1997WO1997038715A1 Novel compounds
10/23/1997WO1997038714A1 Novel compounds
10/23/1997WO1997038695A1 Dhea combination therapy
10/23/1997WO1997038690A1 Agent for inhibiting leukocyte invasion of tissues
10/23/1997WO1997038689A2 Enteric-coated pharmaceutical compositions of mycophenolate
10/23/1997WO1997038688A1 Methods of treating immunopathologies using polyunsaturated fattyacids
10/23/1997WO1997038686A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
10/23/1997WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration
10/23/1997DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis
10/23/1997CA2252426A1 Pharmaceutical grade botanical drugs
10/23/1997CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997CA2252082A1 Hybrid interferon compositions and methods of use
10/23/1997CA2251780A1 Methods of treating immunopathologies using polyunsaturated fatty acids
10/23/1997CA2251733A1 Dhea combination therapy
10/23/1997CA2251642A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/23/1997CA2251204A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
10/23/1997CA2251115A1 Novel rantes homolog from prostate
10/23/1997CA2250943A1 Piperidinylpyrimidine derivatives
10/23/1997CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/22/1997EP0801951A2 Novel uses of Il-4 and/or Il-10, and antibodies against the same
10/22/1997EP0801946A2 Use of salicin as agent against irritation in cosmetic and topical dermatological compositions
10/22/1997EP0801945A2 Use of ferulic acid glucosides as agents against irritation in cosmetic or topical dermatological compositions
10/22/1997EP0801686A1 Process for preparing cyclosporin a
10/22/1997EP0801679A1 Monoclonal antibodies which promote central nervous system remyelination
10/22/1997EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/22/1997EP0576426B1 Ryegrass pollen allergen
10/22/1997CN1036196C 1,3-Oxatholane nucleoside analogues
10/21/1997US5679692 Unbridged bis-aryl carbinol derivatives, compositions and methods of use
10/21/1997US5679688 Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
10/21/1997US5679678 Analgesic and antiinflammatory agents
10/21/1997US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
10/21/1997US5679644 Methods of treating diseases using triterpenoid acid derivatives
10/21/1997US5679641 Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes
10/21/1997US5679354 Vaccine having an iscom-like structure comprising at least one lipid and one saponin and being free of incorporated antigens
10/21/1997US5679352 Synthetic Haemophilus influenzae conjugate vaccine
10/21/1997CA1339505C 2-substituted coumaran derivatives
10/16/1997WO1997038118A1 Defective viral vaccine particles obtained in vivo or ex vivo
10/16/1997WO1997038104A1 Il-6 mutein
10/16/1997WO1997038103A1 Il-6 mutein
10/16/1997WO1997038101A1 Scf analog compositions and methods
10/16/1997WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997WO1997038011A1 Non-dendritic backbone peptide carrier
10/16/1997WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997WO1997037988A1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action
10/16/1997WO1997037972A1 Novel vitamin d analogues
10/16/1997WO1997037687A1 Novel product and process for t lymphocyte veto
10/16/1997WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997WO1997037651A1 Method for producing a drug (trecresan) with nootropic activity
10/16/1997WO1997037648A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
10/16/1997WO1997024138A3 Medical use of proteases
10/16/1997WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997CA2251819A1 Novel product and process for t lymphocyte veto
10/16/1997CA2251464A1 Non-dendritic backbone peptide carrier
10/16/1997CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997CA2250755A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
10/16/1997CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/15/1997EP0801132A2 Staphylococcal FtsH protein
10/15/1997EP0800579A2 Combination gene delivery vehicles
10/15/1997EP0800578A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
10/15/1997EP0800539A1 Novel cyclodextrin-derivatives and methods for the preparation thereof
10/15/1997EP0800536A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
10/15/1997EP0800535A1 Fibronectin adhesion inhibitors
10/15/1997EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/15/1997EP0800514A1 Substituted imides as tnf inhibitors
1 ... 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 ... 1172